Drug name - Onureg

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8846628 CELGENE CORP Oral formulations of cytidine analogs and methods of use thereof Jun, 2030

(7 years from now)

Drugs and Companies using AZACITIDINE ingredient

Treatment: Continued treatment of adults with acute myeloid leukemia who achieved first complete remission (cr) or cr with incomplete blood count recovery following intensive induction chemotherapy and are not able to complete intensive curative therapy


More Information on Dosage
Strength Dosage Availability
200MG TABLET;ORAL Prescription
300MG TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.